NCT05530122已完成不适用
The Long-term Outcome of Patients With Ulcerative Colitis Treated With First Trial of Biological.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 192
- 主要终点
- Response to treatment
研究概览
简要总结
To study the long-term clinical outcome of patients with ulcerative colitis treated with first trial of biological therapy.
详细描述
UC patients treated with at least one biological in Tampere University Hospital between January 2009 and January 2020 were identified and reviewed from patient records.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Other
入排标准
- 年龄范围
- 16 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients treated for ulcerative colitis for the first trial of biological
排除标准
- •Age under 16 years
结局指标
主要结局
Response to treatment
时间窗: within 5 years
Need for colectomy or enhancement of treatment within follow-up
Side-effects
时间窗: within 5 years
treatment related side-effects reported
次要结局
未报告次要终点
研究者
Heli T Eronen
Principal investigator
Tampere University Hospital
相似试验
已完成
不适用
An Observational Study to Assess Change in Disease Activity and Adverse Events of Rinvoq in Adult Participants With Moderate to Severe Ulcerative Colitis (UC) in JapanUlcerative ColitisNCT05791526AbbVie308
已完成
2 期
Metformin in Patients With Ulcerative Colitis Treated With MesalamineInflammatory Bowel DiseasesNCT05553704Tanta University60
已完成
3 期
Curcumin + Aminosalicylic Acid (5ASA) Versus 5ASA Alone in the Treatment of Mild to Moderate Ulcerative ColitisUlcerative ColitisNCT01320436Sheba Medical Center50
已完成
不适用
nderstanding the impact of Ulcerative Colitis and its associated disease burden on patientsK51.9Ulcerative colitis, unspecifiedDRKS00009858AbbVie Deutschland GmbH & Co. KG1,890
已完成
不适用
Retrospective Observational Comparison Study Between Ustekinumab and Tofacitinib as Third Line Therapy in a Multicenter Cohort of Patients With Refractory Ulcerative Colitis.Ulcerative ColitisNCT05728008IRCCS San Raffaele100